Rx Patent Reform Gets Renewed Interest From GOP As Alternative To Price Negotiation

 
• By Derrick Gingery

A Republican congressman and witness discuss shortened IP protections while criticizing Nancy Pelosi's drug price negotiation plan.

Capitol House
The House Ways and Means Committee is one of several committees to consider the Pelosi drug pricing bill. • Source: File photo

More from Legislation

More from Pink Sheet